Calogero Cipolla

Prof. Dr. Calogero Cipolla

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2019 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
GGGiuseppa Graceffa
Giuseppa Graceffa
Renato PatroneRenato Patrone
Renato Patrone
SVSalvatore Vieni
Salvatore Vieni
SCSilvia Campanella
Silvia Campanella
SCSergio Calamia
Sergio Calamia
CCCalogero Cipolla
Calogero Cipolla
The association between Hashimoto’s thyroiditis (HT) and papillary thyroid carcinoma (PTC) is a controversial question that is still under debate, its pathological significance and the eventual clinical implications of this association remaining unclear. The data regarding 305 patients were retrospectively analyzed. The patients were divided in two different groups. A first group made up of 142 patients undergoing surgery for differentiated thyroid carcinoma was compared to a control group of 142 analogous subjects operated for normofunctioning goiter. A second group was made up of 163 patients who had undergone total thyroidectomy (TT) with pre-operative diagnosis of HT. In the first group of patients an association with HT was found in 28,6% of the patients with final histopathological diagnosis of PTC versus 7,7% of the patients with histopathological diagnosis of multinodular goiter, which was a significant difference (p < 0.001). In the second group, the association with PTC was found in 43 (40,2%) cases of HT nodular variant and in 3 cases (8,1%) of HT diffuse variant (p < 0.001). The relationship between HT and PTC is still far from clear and represents an unresolved issue. Our own study has underlined the frequent coexistence of these two pathologies, an aspect not to be neglected in clinical practice. Patients receiving HT diagnosis should undergo careful follow-up and, especially those with the nodular variant, should undergo a frequent both clinical and cytological evaluation of the nodular lesions, taking always into great consideration the surgical approach of total thyroidectomy.

Verified
Journal Article
Open access
PDF file
Celeste Caruso BavisottoCeleste Caruso Bavisotto
Celeste Caruso Bavisotto
CCCalogero Cipolla
Calogero Cipolla
GGGiuseppa Graceffa
Giuseppa Graceffa
Rosario BaroneRosario Barone
Rosario Barone
FBFabio Bucchieri
Fabio Bucchieri
Francesca RappaFrancesca Rappa
Francesca Rappa
The thyroid is a major component of the endocrine system and its pathology can cause serious diseases, e.g., papillary carcinoma (PC). However, the carcinogenic mechanisms are poorly understood and clinical useful biomarkers are scarce. Therefore, we determined if there are quantitative patterns of molecular chaperones in the tumor tissue and circulating exosomes that may be useful in diagnosis and provide clues on their participation in carcinogenesis. Hsp27, Hsp60, Hsp70, and Hsp90 were quantified by immunohistochemistry in PC, benign goiter (BG), and normal peritumoral tissue (PT). The same chaperones were assessed in plasma exosomes from PC and BG patients before and after ablative surgery, using Western blotting. Hsp27, Hsp60, and Hsp90 were increased in PC in comparison with PT and BG but no differences were found for Hsp70. Similarly, exosomal levels of Hsp27, Hsp60, and Hsp90 were higher in PC than in BG, and those in PC were higher before ablative surgery than after it. Hsp27, Hsp60, and Hsp90 show distinctive quantitative patterns in thyroid tissue and circulating exosomes in PC as compared with BG, suggesting some implication in the carcinogenesis of these chaperones and indicating their potential as biomarkers for clinical applications.

1 April 2010 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CCCalogero Cipolla
Calogero Cipolla
SFSalvatore Fricano
Salvatore Fricano
SVSalvatore Vieni
Salvatore Vieni
GGGiuseppa Graceffa
Giuseppa Graceffa
GLGaspare Licari
Gaspare Licari
MLMario A. Latteri
Mario A. Latteri

6 December 2006 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
SVSalvatore Vieni
Salvatore Vieni
DCDaniela Cabibi
Daniela Cabibi
CCCalogero Cipolla
Calogero Cipolla
SFSalvatore Fricano
Salvatore Fricano
GGGiuseppa Graceffa
Giuseppa Graceffa
MLMario Adelfio Latteri
Mario Adelfio Latteri
Secretory mammary carcinoma is a rare breast neoplasia originally described in children but sometimes also found in adults. It presents a more favourable outcome than more common histological types of breast carcinoma; published literature in fact reports only a few cases with axillary lymph node metastases and only four cases with distant metastases. In this paper we report a rare case of secretory breast carcinoma with axillary lymph node metastases in a 33-year-old woman. To our knowledge, this is the first case of secretory carcinoma involving biopsy of the sentinel lymph node and investigation of the e-cadherin expression. We found positivity for e-cadherin, which would support the hypothesis that this type of tumour is a variant of the infiltrating ductal carcinoma. After a careful analysis of reported data, we have come to the conclusion that the treatment of choice for patients with secretory breast carcinoma should be conservative surgery with sentinel lymph node biopsy, followed by accurate follow-up. We are of the opinion that while post-operative radiotherapy is indicated in adult patients who have undergone quadrantectomy, it should not be used in children. Although several cases of secretory carcinoma have been treated with adjuvant chemotherapy, there are still no reliable data regarding the real value of such a choice.

1 January 2008 in World Journal of Gastroenterology
Verified
Journal Article
Open access
NGNello Grassi
Nello Grassi
CCCalogero Cipolla
Calogero Cipolla
ATAdriana Torcivia
Adriana Torcivia
SMStefano Mandalà
Stefano Mandalà
GGGiuseppa Graceffa
Giuseppa Graceffa
FLFederica Latteri
Federica Latteri
Gastrointestinal stromal tumour of the rectum: Report of a case and review of literature

1 February 2014 in Acta Radiologica
Verified
Journal Article
Closed access
GCGiuseppe Caruso
Giuseppe Caruso
CCCalogero Cipolla
Calogero Cipolla
RCRenato Costa
Renato Costa
AMAlessandra Morabito
Alessandra Morabito
SLStefania Latteri
Stefania Latteri
MLMario Adelfio Latteri
Mario Adelfio Latteri
Background: Preoperative lymphoscintigraphy is without doubt a valid method for the detection of the sentinel lymph node (SLN). There has been considerable debate regarding the optimal site for the introduction of the tracer; various sites include peritumoral (PT), periareolar (PA), subdermal, and intradermal injection. Purpose: To evaluate retrospectively the lymphoscintigraphic identification rate of peritumoral (PT) injection versus subdermal periareolar (PA) injection in the detection of SLNs in breast cancer. Material and Methods: Between October 2002 and December 2011, a cohort of 906 consecutive patients with biopsy proven breast cancer underwent 914 SLN biopsy procedures. A total of 339 procedures (Group A) were performed using a PT deep injection of radiotracer while 575 procedures (Group B) adopted a subdermal PA injection of radiotracer towards the upper outer quadrant, regardless of the site of the carcinoma. All the patients underwent synchronous excision of the breast cancer and SLN biopsy. Results: SLNs were identified in the lymphoscintigram in 308/339 cases (90.85%) of Group A (PT injection) and in 537/575 cases (93.39%) of Group B (PA injection). Furthermore, in 2/339 patients (0.58%) of Group A, internal mammary lymph nodes were found at lymphoscintigraphy, whereas no internal mammary sentinel nodes were found in the Group B patients. The intraoperative identification rate of axillary SLNs was 99.41% (337 of 339) in the Group A patients and 99.65% (573 of 575) in the Group B patients. There was no significant difference in the two groups between the incidence of the number of SLNs detected and the incidence of identification of positive SLNs. Conclusion: PT versus PA injection of radiotracer showed comparable success rates for axillary SLN identification, and can be considered a rapid and reliable method.